Evidence map›Paper›PMID 38996039›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Retrospective Analysis of Cholera/Acute Watery Diarrhea Outbreaks in Ethiopia From 2001 To 2023: Incidence, Case Fatality Rate, and Seasonal and Multiyear Epidemic Patterns.

Yeshambel Worku Demlie, Abel Gedefaw, Yeonji Jeon, Dejene Hailu, Tomas Getahun, Ondari D Mogeni, David Mukasa, Geun Hyeog Jang, Gi Deok Pak, Deok Ryun Kim and 7 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Coverage of Two-Dose Preemptive Cholera Mass Vaccination Campaign in High-Priority Hotspots in Shashemene, Oromia Region, Ethiopia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  6. Dissecting Water, Sanitation, and Hygiene (WaSH) to Assess Risk Factors for Cholera in Shashemene, Oromia Region, Ethiopia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  7. Ethiopia National Cholera Elimination Plan 2022-2028: Experiences, Challenges, and the Way Forward.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yeshambel Worku DemlieDiseases Surveillance and Response Directorate, Ethiopia Public Health Institute, Addis Ababa, Ethiopia.
Abel GedefawClinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.
Yeonji JeonClinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.
Dejene HailuClinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.
Tomas GetahunClinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Ondari D MogeniClinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.
David MukasaBiostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea.
Geun Hyeog JangBiostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea.
Gi Deok PakBiostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea.
Deok Ryun KimBiostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea.
Edlawit Mesfin GetachewClinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Biruk YeshitelaBacterial and Viral Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Samuyel Ayele AbebeData Science Division, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Moti EdosaDiseases Surveillance and Response Directorate, Ethiopia Public Health Institute, Addis Ababa, Ethiopia.
Mesfin WossenDiseases Surveillance and Response Directorate, Ethiopia Public Health Institute, Addis Ababa, Ethiopia.
Mekonnen TeferiClinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Se Eun ParkClinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.ORCID 0000-0002-1632-3045

Funding

Community Chest of Korea CHMTD05083-030Korea Support Committee CHMTD05083-010LG Electronics CHMTD05083-020
6 · The paper itself

Abstract

backgroundThe Ethiopian government has developed the multisectoral cholera elimination plan (NCP) with an aim of reducing cholera incidence and case fatality rate (CFR). To better understand and monitor the progress of this plan, a comprehensive review of national cholera epidemiology is needed.

methodsReported data on cholera/acute watery diarrhea (AWD) cases in the past 20 years were extracted from the Ethiopian Public Health Institute and World Health Organization databases. Descriptive statistics, Pearson χ2, and logistic regression analyses were conducted.

resultsFrom January 2001 to November 2023, a total of 215 205 cholera/AWD cases, 2355 deaths with a cumulative CFR of 1.10% (95% confidence interval [CI], 1.092-1.095), and a mean annual incidence rate of 8.9/100 000 (95% CI, 6.5-11.3) were reported. Two major upsurges of cholera epidemics were found in the last two decades with mean attack rate (AR) of 20.57/100 000 in 2006-2010 and 14.83/100 000 in 2016-2020. Another resurgence of outbreaks occured in 2021-2023 (mean AR, 8.63/100 000). In 2015-2023, 54.0% (53 990/99 945) of cases were aged 15-44 years. National cholera CFR (3.13% [95% CI: 2.1-4.5]) was the highest in 2022. The 2015-2023 cumulative cholera CFR was different across regions: Benishangul Gumuz (6.07%), Gambela (1.89%), Sidama (1.42%), Southern Nation, Nationalities, and Peoples' (1.34%), Oromia (1.10%), and Amhara (1.09%). Cholera/AWD patients in older adults (≥45 years), severe dehydration, peak rainy season (June-August), and outpatients were associated with higher risk of death.

conclusionsCholera has been a public health problem in Ethiopia with case fatalities still above the global target. Case management needs to be improved particularly in outpatients and older populations. Outbreak preparedness should be rolled out well in advance of the typical rainy seasons. Significant investments are essential to advance the cholera surveillance system at healthcare setting and community level. Underlying factors of cholera deaths per areas should be further investigated to guide appropriate interventions to meet the NCP target by 2028.

Indexed as

CholeraDiarrheaDisease OutbreaksSeasonsAdolescentAdultAgedChildChild, PreschoolEthiopiaFemaleHumansIncidenceInfantMaleMiddle Agedcase fatality ratecholeraEthiopiaincidenceseasonality

Identifiers

PMID38996039
PMCPMC11244192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.